Mydecine Innovations Group (TSE:MYCO)
CNQX:MYCO
Holding TSE:MYCO?
Track your performance easily

Mydecine Innovations Group (MYCO) Financial Statements

94 Followers

Mydecine Innovations Group Financial Overview

Mydecine Innovations Group's market cap is currently ―. The company's EPS TTM is C$-0.283; its P/E ratio is -0.04; Mydecine Innovations Group is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -2.30MC$ -665.22KC$ 1.23MC$ -2.32MC$ -10.22M
EBITDAC$ -2.30MC$ -665.22KC$ 1.23MC$ -2.32MC$ -10.21M
Net Income Common StockholdersC$ -2.67MC$ -1.02MC$ -17.62MC$ -2.56MC$ -10.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 13.61KC$ 20.35KC$ 37.65KC$ 40.46KC$ 565.71K
Total AssetsC$ 158.52KC$ 213.41KC$ 212.38KC$ 1.03MC$ 2.22M
Total DebtC$ 6.14MC$ 5.78MC$ 5.42MC$ 5.25MC$ 5.02M
Net DebtC$ 6.13MC$ 5.76MC$ 5.39MC$ 5.21MC$ 4.45M
Total LiabilitiesC$ 15.61MC$ 13.05MC$ 12.13MC$ 10.11MC$ 10.27M
Stockholders EquityC$ -15.45MC$ -12.84MC$ -11.92MC$ -9.08MC$ -8.05M
Cash Flow-
Free Cash FlowC$ -9.75KC$ -17.30KC$ 951.81KC$ -819.54KC$ -3.00M
Operating Cash FlowC$ -9.75KC$ -17.30KC$ 951.81KC$ -819.54KC$ -3.00M
Investing Cash Flow--C$ 1.00C$ 25.20KC$ 500.00K
Financing Cash Flow--C$ -931.50KC$ 824.50KC$ 2.50M
Currency in CAD

Mydecine Innovations Group Earnings and Revenue History

Mydecine Innovations Group Debt to Assets

Mydecine Innovations Group Cash Flow

Mydecine Innovations Group Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis